JP Morgan analyst Jeremy Tonet downgrades Crestwood Equity Partners (NYSE:CEQP) from Overweight to Neutral and lowers the price target from $31 to $28.
NuCana PLC (NASDAQ: NCNA) shares are trading lower by 36.19% to $0.79 Monday morning after the European Patent Office said NuCana's 190 patent is not valid.
What Else?
Incyte Corporation (NASDAQ: INCY) released topline results from its Phase 3 TRuE-AD3 study evaluating the safety and efficacy of ruxolitinib cream (Opzelura) in children with